1. Home
  2. NSPR vs KOSS Comparison

NSPR vs KOSS Comparison

Compare NSPR & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$0.73

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

Logo Koss Corporation

KOSS

Koss Corporation

N/A

Current Price

$3.30

Market Cap

32.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
KOSS
Founded
2005
1953
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
32.8M
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
NSPR
KOSS
Price
$0.73
$3.30
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 336.1K
24.0K
Earning Date
11-12-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 55.56
EPS
N/A
★ N/A
Revenue
$2,310,000.00
★ $13,020,773.00
Revenue This Year
$9.14
N/A
Revenue Next Year
$105.44
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.14
52 Week Low
$0.43
$2.93
52 Week High
$2.22
$5.06

Technical Indicators

Market Signals
Indicator
NSPR
KOSS
Relative Strength Index (RSI) 59.13 42.61
Support Level $0.66 $2.93
Resistance Level $0.77 $4.14
Average True Range (ATR) 0.10 0.19
MACD 0.04 0.00
Stochastic Oscillator 74.86 42.26

Price Performance

Historical Comparison
NSPR
KOSS

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

Share on Social Networks: